Abstract
Peptide arrays are useful tools to characterize antibodies, to determine sequence specificities of enzymes, or to find interaction partners to given peptide sequences. One widely-used format for such arrays is a cellulose sheet with hundreds of synthetic peptides bound to it. These SPOT arrays have been used successfully in a broad range of applications since their invention at the beginning of the nineties. The simplicity and robustness of this method along with the fully automated synthesis to generate custom arrays with high peptide densities made the SPOT method popular. A drawback of the SPOT method is the use of large reagent volumes and the limited throughput with only one copy of the library. CelluSpots represent a new method that retains the advantages of the SPOT method but allows the production of hundreds of identical copies on microscope slides for parallel screenings with low sample volumes.
Keywords: Antibody profiling, CelluSpots, kinase substrates, peptide arrays, peptide conjugates, protein interaction, SPOT
Mini-Reviews in Organic Chemistry
Title: CelluSpots Arrays as an Alternative to Peptide Arrays on Membrane Supports
Volume: 8 Issue: 2
Author(s): Daniel Maisch, Ian Schmitz and Ole Brandt
Affiliation:
Keywords: Antibody profiling, CelluSpots, kinase substrates, peptide arrays, peptide conjugates, protein interaction, SPOT
Abstract: Peptide arrays are useful tools to characterize antibodies, to determine sequence specificities of enzymes, or to find interaction partners to given peptide sequences. One widely-used format for such arrays is a cellulose sheet with hundreds of synthetic peptides bound to it. These SPOT arrays have been used successfully in a broad range of applications since their invention at the beginning of the nineties. The simplicity and robustness of this method along with the fully automated synthesis to generate custom arrays with high peptide densities made the SPOT method popular. A drawback of the SPOT method is the use of large reagent volumes and the limited throughput with only one copy of the library. CelluSpots represent a new method that retains the advantages of the SPOT method but allows the production of hundreds of identical copies on microscope slides for parallel screenings with low sample volumes.
Export Options
About this article
Cite this article as:
Maisch Daniel, Schmitz Ian and Brandt Ole, CelluSpots Arrays as an Alternative to Peptide Arrays on Membrane Supports, Mini-Reviews in Organic Chemistry 2011; 8 (2) . https://dx.doi.org/10.2174/157019311795177736
DOI https://dx.doi.org/10.2174/157019311795177736 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis of Pyridine and Spiropyridine Derivatives Derived from 2-aminoprop- 1-ene-1,1,3-tricarbonitrile Together with their c-Met Kinase and Antiproliferative Evaluations
Anti-Cancer Agents in Medicinal Chemistry Targetin g Human Tel omerase by Antisens e Oligonucleotides and Ribozymes
Current Medicinal Chemistry - Anti-Cancer Agents Active Targeting Strategies for Anticancer Drug Nanocarriers
Current Drug Delivery Cancer Stem Cells and the Tumor Microenvironment: Soloists or Choral Singers
Current Pharmaceutical Biotechnology In Silico Modeling for the Design of 2-substitted Benzimidazole Derivatives, and Prediction of Activity as Procaspase-3 Activators and Apoptosis Inducer
Letters in Drug Design & Discovery Interleukin-26, a Highly Cationic T-Cell Cytokine Targeting Epithelial Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Immunomodulatory Drugs (IMiDs™): A New Treatment Option for Myelodysplastic Syndromes
Current Pharmaceutical Biotechnology Inhibition of Cellular Proliferation by Drug Targeting of Cyclin-Dependent Kinases
Current Pharmaceutical Biotechnology Polyketide Natural Products, Acetogenins from Graviola (Annona muricata L), its Biochemical, Cytotoxic Activity and Various Analyses Through Computational and Bio-Programming Methods
Current Pharmaceutical Design Viruses in Semen and Male Genital Tissues - Consequences for the Reproductive System and Therapeutic Perspectives
Current Pharmaceutical Design CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer
Current Cancer Drug Targets Potential Clinical Applications of the CXCR4 Antagonist Bicyclam AMD3100
Mini-Reviews in Medicinal Chemistry Melatonin, A Natural Programmed Cell Death Inducer in Cancer
Current Medicinal Chemistry Evaluation of In-Vitro Multidrug Resistance Reversal Activities of HZ08 analogues with Improved Soluble Property
Letters in Drug Design & Discovery γ-Secretase Substrates and their Implications for Drug Development in Alzheimer's Disease
Current Topics in Medicinal Chemistry Modulation of Cell Death in Age-Related Diseases
Current Pharmaceutical Design Cytotoxic and Antitumoral Activity of N-(9H-purin-6-yl) Benzamide Derivatives and Related Water-soluble Prodrugs
Current Molecular Pharmacology Developments Towards a Prophylactic Hepatitis C Virus Vaccine
Current Immunology Reviews (Discontinued) Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma
Current Cancer Therapy Reviews Idiotype Vaccines for Human B-Cell Malignancies
Current Pharmaceutical Design